Consensus guidelines for the management of patients with liver metastases from digestive (neuro) endocrine tumors: Foregut, midgut, hindgut, and unknown primary

Autor: Steinmüller, T., Kianmanesh, R., Falconi, Massimo, Scarpa, Aldo, Taal, B., Kwekkeboom, D., Lopes, J., Perren, A., Nikou, G., Yao, J., Fave, G. D., O'Toole, D., Ahlman, H., Arnold, R., Auernhammer, C., Caplin, M., Christ, E., Couvelard, A., Herder, W. D., Eriksson, B., Ferone, D., Goretzki, P., Gross, D., Hyrdel, R., Jensen, R., Kaltsas, G., Keleştimur, F., Klöppel, G., Knapp, W., Knigge, U., Komminoth, P., Körner, M., Kos Kudła, B., Krenning, E., Kulke, M., Kvols, L., Manfredi, Riccardo, Mcnicol, A., Niederle, B., Nilsson, O., Öberg, K., O'Connor, J., Pape, U., Pavel, M., Plöckinger, U., Ramage, J., Ricke, J., Rindi, G., Ruszniewski, P., Salazar, R., Scoazec, J., Garcia, M. S., Sundin, A., Vullierme, M., Wiedenmann, B., Wildi, S.

Publikováno v: Neuroendocrinology, 87(1), 47-62. Karger

a DRK Kliniken Westend, Berlin , Germany; b UFR Bichat-Beaujon-Louis Mourier, Service de Chirurgie Digestive, Hopital Louis Mourier, Colombes , France; c Medicine and Surgery, General Surgery Section, MED/18 – General Surgery and d Department of Pa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9a23009d7262baa3a862474db5eb779
https://pure.eur.nl/en/publications/914ef156-778f-4a39-a75d-ad28ea2220de

Comparison of 111in-[DTPA]octreotide versus non carrier added 177Lu-[DOTA,Tyr3]-octreotate efficacy in patients with GEP-NET treated intra-arterially for liver metastases

Autor: Limouris, G.S. Poulantzas, V. Trompoukis, N. Karfis, I. Chondrogiannis, S. Triantafyllou, N. Gennimata, V. Moulopoulou, L.-E. Patsouris, E. Nikou, G. Michalaki, V. Fragulidis, G. Paphiti, M. McCready, R.V. Colletti, P.M. Cook, G.J. Rubello, D.

Aim: In patients with progressive, metastatic neuroendocrine tumors (NET), intra-arterial radionuclide infusions with high activities of 111In-[DTPA]-octreotide and more recently with non-carrier added (nca) 177Lu-[DOTA, Tyr3]-octreotate have been pe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::85eac6b01650913310cfb2203de0571f
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3124763

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

ENETS consensus guidelines for the management of brain, cardiac and ovarian metastases from neuroendocrine tumors

Autor: Pavel, M, Grossman, A, Arnold, R, Perren, A, Kaltsas, G, Steinmüller, T, de Herder, W, Nikou, G, Plöckinger, U, Lopes, Jm, Sasano, H, Buscombe, J, Lind, P, O'Toole, D, Oberg, K, Collaborators: Caplin M, Palma de Mallorca Consensus Conference P. a. r. t. i. c. i. p. a. n. t. s., Chen, Yj, Cioppi, F, Eriksson, B, Falconi, M, Fazio, N, Gross, D, Kianmanesh, R, Komminoth, Gp, Kos Kudła, B, Kulke, M, Kwekkeboom, D, Lebtahi, R, Lesurtel, M, Mallath, M, Nilsson, O, O'Connor, J, Pape, Uf, Papotti, Mauro Giulio, Ramage, J, Rindi, G, Ruszniewski, P, Scoazec, Jy, Sevilla Garcia, I, Sundin, A, Van Cutsem, E, Wiedenmann, B.

Publikováno v: Neuroendocrinology, 91(4), 326-332. Karger
Pavel, Marianne; Grossman, Ashley; Arnold, Rudolf; Perren, Aurel; Kaltsas, Gregory; Steinmüller, Thomas; de Herder, Wouter; Nikou, George; Plöckinger, Ursula; Lopes, Jose Manuel; Sasano, Hironobu; Buscombe, John; Lind, Peter; O'Toole, Dermot; Oberg, Kjell (2010). ENETS consensus guidelines for the management of brain, cardiac and ovarian metastases from neuroendocrine tumors. Neuroendocrinology, 91(4), pp. 326-32. Basel: Karger 10.1159/000287277

ENETS consensus guidelines for the management of brain, cardiac and ovarian metastases from neuroendocrine tumors

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7f196b5c3e473324a4821cf73344b15
http://ora.ox.ac.uk/objects/uuid:92344183-f0cf-4ef6-8e32-1a614360decd

Well-differenitated duodenal tumor/carcinoma(excluding gastrinomas)

Autor: Jensen, R., Rindi, G., Arnold, R., Lopes, J., Brandi, M., Bechstein, W., Christ, E., Taal, B., Knigge, U., Ahlman, H., Kwekkeboom, D., O'Toole, D., Cadiot, G., Caplin, M., Chung, D., Couvelard, A., Herder, W. D., Fave, G. D., Eriksson, B., Falchetti, A., Falconi, Massimo, Ferone, D., Goretzki, P., Gross, D., Hochhauser, D., Hyrdel, R., Kaltsas, G., Keleştimur, F., Kianmanesh, R., Knapp, W., Komminoth, P., Körner, M., Kos Kudła, B., Kvols, L., Lewington, V., Manfredi, Riccardo, Mcnicol, A., Mitry, E., Niederle, B., Nikou, G., Nilsson, O., Öberg, K., O'Connor, J., Pauwels, S., Pape, U., Pavel, M., Perren, A., Plöckinger, U., Ramage, J., Ricke, J., Ruszniewski, P., Salazar, R., Sauvanet, A., Scarpa, Aldo, Scoazec, J., Garcia, M. S., Steinmüller, T., Sundin, A., Cutsem, E. V., Vullierme, M., Wiedenmann, B., Wildi, S., Yao, J., Zgliczynski, S.

Publikováno v: Neuroendocrinology, 84(3), 165-172. Karger

a Digestive Diseases Branch, NIDDK, NIH, Bethesda, Md. , USA; b Dipartimento di Patologia e Medicina di Laboratorio, Universita di Parma, Parma , Italy; c Division of Gastroenterology and Endocrinology, Department of Internal Medicine, Philipps Unive

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bf0db553f286963186fbfc4063c05ff
https://pure.eur.nl/en/publications/dccd146a-ba81-4158-acf6-67e64e523b64